To screen or not to screen for osteoporosis amongst post-menopausal women with one prior osteoporotic fracture in Greece

被引:1
|
作者
Souliotis, Kyriakos [1 ,2 ]
Golna, Christina [2 ]
Golnas, Paul [2 ]
Markakis, Ioannis-Anestis [2 ]
Makras, Polyzois [3 ,4 ]
机构
[1] Univ Peloponnese, Dept Social & Educ Policy, Corinth, Greece
[2] Hlth Policy Inst, Maroussi, Greece
[3] 251 Hellen Air Force & VA Gen Hosp, Dept Endocrinol & Diabet, Athens, Greece
[4] 251 Hellenic Air Force & VA Gen Hosp, Dept Med Res, Athens, Greece
关键词
Osteoporosis burden; Postmenopausal; Osteoporotic fractures; Modelling; Screening; Cost of care; COST-EFFECTIVENESS; RISK; MORTALITY;
D O I
10.1007/s40520-022-02183-z
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Screening and linkage to care (SLTC) for osteoporosis is suboptimal in several settings. In Greece, it is estimated that only up to 8.6% of postmenopausal women are SLTC for osteoporosis, despite having suffered a previous fracture. Aims This study aims to estimate the impact of comprehensive screening on future fracture burden amongst post-menopausal women aged 50-74, with one prior osteoporotic fracture, in Greece. Methods We developed a cohort stochastic model, based on published epidemiological and clinical data, to assess impact of screening on future fracture burden in two scenarios: a current, assuming an 8.6% background SLTC, and a completely hypothetical, assuming 100% SLTC. Results Amongst a cohort of 50,000 post-menopausal women aged 50-74, with one prior osteoporotic fracture, applying the hypothetical versus the current scenario would result in a reduction in deaths (-0.6%) and fractures (-4.3%) over 10 years. The hypothetical scenario leads to greater reductions in costs associated with vertebral (-8.1%) and hip (-5.5%) fractures, followed by other non-vertebral (-3.0%) and forearm (-2.5%) fractures. In the hypothetical scenario, treatment initiations and total screenings increased almost tenfold versus the current scenario, at an estimated direct incremental cost of 27.83euro per woman per year in the cohort. Discussion Our study adds to the existing evidence on the impact of screening to prevent fractures amongst post-menopausal women. Despite being based on a stochastic model, our study confirms findings most recently published in the literature. Conclusions Our study models the positive public health impact of increasing SLTC levels amongst post-menopausal women with a prior osteoporotic fracture.
引用
收藏
页码:2473 / 2481
页数:9
相关论文
共 36 条
  • [21] Prediction of Hip Fracture in Post-menopausal Women using Artificial Neural Network Approach
    Ho-Le, Thao P.
    Center, Jacqueline R.
    Eisman, John A.
    Nguyen, Tuan V.
    Nguyen, Hung T.
    2017 39TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2017, : 4207 - 4210
  • [22] Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA
    Asche, C.
    Nelson, R.
    McAdam-Marx, C.
    Jhaveri, M.
    Ye, X.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (08) : 1427 - 1436
  • [23] Suboptimal medication adherence may favor the progression of vertebral fractures in women with post-menopausal osteoporosis treated with denosumab
    Betella, Nazarena
    Biamonte, Emilia
    Matarazzo, Carmine
    Piccini, Sara
    Olivetti, Roberto
    Cellini, Miriam
    Lania, Andrea G.
    Mazziotti, Gherardo
    MINERVA ENDOCRINOLOGICA, 2020, 45 (03) : 165 - 171
  • [24] MOF/Hip Fracture Ratio in a Belgian Cohort of Post-menopausal Women (FRISBEE): Potential Impact on the FRAX® Score
    Mugisha, A.
    Bergmann, P.
    Kinnard, V.
    Iconaru, L.
    Baleanu, F.
    Charles, A.
    Surquin, M.
    Rozenberg, S.
    Benoit, F.
    Body, J. J.
    CALCIFIED TISSUE INTERNATIONAL, 2021, 109 (06) : 600 - 604
  • [25] Treatments for post-menopausal osteoporotic women, what's new? How can we manage long-term treatment?
    Herrero, Soledad
    Pico, Yolanda
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 779 : 8 - 21
  • [26] Using Radon transform of standard radiographs of the hip to differentiate between post-menopausal women with and without fracture of the proximal femur
    Boehm, H. F.
    Lutz, J.
    Koerner, M.
    Mutschler, W.
    Reiser, M.
    Pfeifer, K. -J.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (02) : 323 - 333
  • [27] Dosing time-dependent effect of raloxifene on plasma plasminogen activator inhibitor-1 concentrations in post-menopausal women with osteoporosis
    Ando, Hitoshi
    Otoda, Toshiki
    Ookami, Hitoshi
    Nagai, Yukihiro
    Inano, Akihiro
    Takamura, Toshinari
    Ushijima, Kentarou
    Hosohata, Keiko
    Matsushita, Eiki
    Saito, Tetsuo
    Kaneko, Shuichi
    Fujimura, Akio
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 (03) : 227 - 232
  • [28] Evidence for the cardiovascular effects of osteoporosis treatments in randomized trials of post-menopausal women: A systematic review and Bayesian network meta-analysis
    Seeto, Alexander H.
    Tadrous, Mina
    Gebre, Abadi K.
    Lewis, Joshua R.
    Fink, Howard A.
    Ebeling, Peter R.
    Rodriguez, Alexander J.
    BONE, 2023, 167
  • [29] Low BMD is an independent predictor of fracture and early menopause of mortality in post-menopausal women - A 34-year prospective study
    Svejme, Ola
    Ahlborg, Henrik G.
    Nilsson, Jan-Ake
    Karlsson, Magnus K.
    MATURITAS, 2013, 74 (04) : 341 - 345
  • [30] Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy
    Schousboe, J. T.
    Bauer, D. C.
    Nyman, J. A.
    Kane, R. L.
    Melton, L. J.
    Ensrud, K. E.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 (02) : 201 - 210